Terns Pharmaceuticals Inc

NASDAQ:TERN  
7.29
-0.41 (-5.32%)
Earnings Announcements

Terns Pharma Reports Q3 2021 Financial Results

Published: 11/15/2021 21:27 GMT
Terns Pharmaceuticals Inc (TERN) - Terns Pharmaceuticals Reports Third Quarter 2021 Financial Results and Corporate Highlights.
Terns Pharmaceuticals Inc - Cash and Equivalents of $177 Million Provides Runway Into 2024.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.63

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.63

More details on our Analysts Page.